Intraperitoneal Chemohyperthermia Using a Closed Abdominal Procedure and Cytoreductive Surgery for the Treatment of Peritoneal Carcinomatosis: Morbidity and Mortality Analysis of 216 Consecutive Procedures
Top Cited Papers
- 1 September 2003
- journal article
- Published by Springer Science and Business Media LLC in Annals of Surgical Oncology
- Vol. 10 (8), 863-869
- https://doi.org/10.1245/aso.2003.01.018
Abstract
Background: Peritoneal carcinomatosis has been regarded as a lethal clinical entity. Recently, aggressive treatments combining intraperitoneal chemohyperthermia (IPCH) with cytoreductive surgery have resulted in long-term survival in selected patients. The aim of this trial was to analyze the mortality and morbidity of 216 consecutive treatments of peritoneal carcinomatosis by IPCH by using a closed abdominal procedure combined with cytoreductive surgery. Methods: Between February 1989 and August 2001, 207 patients who underwent 216 IPCH procedures using a closed abdominal procedure with mitomycin C, cisplatin, or both were prospectively studied. Results: The postoperative mortality and morbidity rates were 3.2% and 24.5%, respectively. The most frequent complications were digestive fistula (6.5%) and hematological toxicity (4.6%). Morbidity was statistically linked with the carcinomatosis stage (P = .016), the duration of surgery (P = .005), and the number of resections and peritonectomy procedures (P = .042). Duration of surgery and carcinomatosis stage were the most common predictors of morbidity. Conclusions: The frequency of complications after IPCH and cytoreductive surgery was mainly associated with the carcinomatosis stage and the extent of the surgical procedure. The IPCH closed abdominal procedure has shown an acceptable frequency of adverse events.Keywords
This publication has 15 references indexed in Scilit:
- Surgery Combined With Peritonectomy Procedures and Intraperitoneal Chemohyperthermia in Abdominal Cancers With Peritoneal Carcinomatosis: A Phase II StudyJournal of Clinical Oncology, 2003
- Second-Look Surgery in Patients With Peritoneal Dissemination From Appendiceal Malignancy: Analysis of Prognostic Factors in 98 PatientsAnnals of Surgery, 2001
- Intraperitoneal chemohyperthermia with mitomycin C for digestive tract cancer patients with peritoneal carcinomatosisCancer, 2000
- Peritoneal carcinomatosis from non-gynecologic malignanciesCancer, 2000
- Analysis of morbidity and mortality in 60 patients with peritoneal carcinomatosis treated by cytoreductive surgery and heated intraoperative intraperitoneal chemotherapyCancer, 1996
- Prognostic Features of 51 Colorectal and 130 Appendiceal Cancer Patients with Peritoneal Carcinomatosis Treated by Cytoreductive Surgery and Intraperitoneal ChemotherapyAnnals of Surgery, 1995
- Peritonectomy ProceduresAnnals of Surgery, 1995
- Study of the Pharmacokinetics of Mitomycin C in Humans during Intraperitoneal Chemohyperthermia with Special Mention of the Concentration in Local TissuesOncology, 1993
- Tolerance of intraperitoneal chemohyperthermia with mitomycin C:in vivostudy in dogsInternational Journal of Hyperthermia, 1992
- Intraperitoneal free cancer cells and their viability in gastric cancerCancer, 1979